This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Stocks Under $10 With DavidPeltier

Putting 2 Biotechs Under the Microscope

By David Peltier | 09/26/16 - 11:32 AM EDT
Stocks in Focus: ARRY, PTIE

This Alert is a look at two low-dollar biotech stocks are making big moves Monday.

First, Array BioPharma (ARRY:Nasdaq) is trading 57% higher today and recently changed hands around $5.70. The company said this morning that its BRAF melanoma treatment met the primary endpoint in a Phase 3 clinical trial.

Earlier this year, Array filed a new drug application with the Food and Drug Administration (FDA) for another type of melanoma and has two other collaboration products in Phase 3 trials. Now that the company is on our radar screen, we plan to do more work on the stock in the coming weeks.

On the other hand, Pain Therapeutics (PTIE:Nasdaq) is down 54% on the session and recently changed hands around $1.27. The company said earlier Monday that its extended release oxycodone treatment, Remoxy, was not approved by the FDA, because of concerns related to abuse-deterrent properties.

Management believes that it can address the FDA within a year, but it will cost another $5 million. In the meantime, Pain Therapeutics has $32.6 million of cash on its debt- free balance sheet. Remoxy is the company’s only product past Phase 1 trials and we believe that investors should avoid the shares.

Regards,

David Peltier
Portfolio Manager, Stock Under $10

3 Stocks To Avoid
Stocks in Focus: ECR

Sometimes you have to kiss some frogs to find a prince.

09/22/16 - 05:05 PM EDT
Picking Up More TherapeuticsMD
Stocks in Focus: TXMD

The company is less than 48 hours removed from the latest milestone in its product pipeline, so we'll buy on weakness.

09/21/16 - 10:38 AM EDT
Stocks Under $10 Weekly Summary

U.S. stocks close out week with a modest gain.

09/23/16 - 05:23 PM EDT

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Special Subscription Bundles

Want more than one service?
Sign up to one of our packaged services and take advantage of amazing savings!

Portfolio
Plus
Real Money Pro
Portfolio
Chairman's Club
Action Alerts PLUS checkmark | Portfolio Plus checkmark | Real Money Pro Portfolio checkmark | Chairman's Club
Stocks Under $10 checkmark | Portfolio Plus checkmark | Real Money Pro Portfolio checkmark | Chairman's Club
Growth Seeker checkmark | Portfolio Plus checkmark | Real Money Pro Portfolio checkmark | Chairman's Club
Dividend Stock
Advisor
checkmark | Portfolio Plus checkmark | Real Money Pro Portfolio checkmark | Chairman's Club
TheStreet
Quant Ratings
checkmark | Portfolio Plus checkmark | Real Money Pro Portfolio checkmark | Chairman's Club
Real Money checkmark | Real Money Pro Portfolio checkmark | Chairman's Club
Real Money Pro checkmark | Real Money Pro Portfolio checkmark | Chairman's Club
Trifecta Stocks checkmark | Chairman's Club
Reality Check checkmark | Chairman's Club
Action Alerts
OPTIONS
checkmark | Chairman's Club
Daily Swing Trade checkmark | Chairman's Club
Top Stocks checkmark | Chairman's Club
Quarterly Call
with Jim Cramer and
Jack Mohr
checkmark | Chairman's Club
Started Now Started Now Started Now

Markets

Chart of I:DJI
DOW 18,098.87 -162.58 -0.89%
S&P 500 2,147.76 -16.93 -0.78%
NASDAQ 5,259.6690 -46.0780 -0.87%

Stocks Under $10 Holdings

Holdings 1

Stocks we would buy right now

Symbol % Portfolio
Weighting
Industry
CAA 3.65% Materials & Construction
JIVE 2.03% Computer Software & Services
Holdings 2

Stocks we would buy on a pullback

Symbol % Portfolio
Weighting
Industry
AUY 1.60% Metals & Mining
BLDR 2.32% Materials & Construction
BTN 3.69% Consumer Durables
DTLK 2.19% Computer Hardware
HBAN 3.83% Banking
IWM 16.87% Financial Services
MDR 2.41% Energy
ON 3.71% Electronics
SNV 3.95% Banking
SONS 3.14% Telecomm
UNIS 1.39% Health Services
ZIXI 2.90% Computer Software & Services
Holdings 3

Stocks we would sell on strength

Symbol % Portfolio
Weighting
Industry
CECE 1.56% Industrial
OSUR 1.95% Health Services